Study at a glance
What was studied?
Researchers studied early placental cells, the mother’s uterine cells during pregnancy and blood samples from pregnant women. They asked how vitamin D compounds relate to cell movement, immune signals and pregnancy outcomes.
What did the studies find?
Some cell movements and immune signals changed. Other measurements, including an immune-cell killing test, showed no clear change. In women at higher risk, later vitamin D blood levels were linked with pregnancy complications. This observational study did not show that supplements prevented complications.
What does this mean?
The studies show particular local responses. They do not prove better fetal development or successful immune tolerance. Immune tolerance means avoiding inappropriate immune attack while keeping useful defence.
What are the limits?
Many experiments were small and used cells outside the body. Some experiments supplied the active vitamin D hormone directly, rather than an ordinary vitamin D3 supplement. One relevant report was available only as an abstract, so its full methods and results could not be assessed. The evidence does not establish a personal pregnancy dose.
Read the full article below ↓Vitamin D can change the behaviour of cells at the maternal-fetal interface. The important question is what those changes establish about fetal development and immune tolerance. Experiments on placental cells, maternal uterine tissue and pregnancy blood samples examine different parts of that question. This review compares five investigations and a relevant abstract-only report. They support local biological responses, but do not demonstrate that increasing vitamin D improves fetal development or establishes successful immune tolerance. Read the shorter account, Placental Vitamin D Signalling, Fetal Development and Immune Tolerance: Study Summary.
Two tissues and several different questions
The placenta contains cells derived from the developing pregnancy. The decidua is maternal uterine tissue altered during pregnancy. They meet at an interface containing structural cells and immune cells. A result from maternal decidual cells is therefore not automatically a result from fetal placental trophoblasts. Nor does either preparation reproduce an intact pregnancy, with its circulation, changing hormones and interactions between tissues. The wider distinction between local metabolism and a measured tissue response is examined in Tissue-Specific Vitamin D Metabolism and Gene Responses: Full Study.
Trophoblast invasion and migration concern cell movement during placental establishment. These are relevant developmental processes, but a laboratory measure of movement is not a measure of fetal growth, organ development or later health. The distinction is central to interpreting the physiological role proposed for vitamin D. A plausible contribution to placental establishment is a hypothesis about how development could be supported, not proof that a supplement improves it.
Immune tolerance also needs a precise meaning. It concerns avoiding inappropriate immune attack while retaining useful defence. Lower production of a signalling molecule does not establish that whole function. A convincing clinical account would need to connect the cellular response with appropriate maternal-fetal immune behaviour and a meaningful pregnancy outcome. The studies here do not complete that connection. The general physiological concept is introduced in Vitamin D and Immune Tolerance.
Vitamin D forms are not interchangeable
Vitamin D3, or cholecalciferol, is not the same compound as calcitriol, the active hormone. The circulating precursor 25-hydroxyvitamin D can be converted locally into calcitriol by an activating enzyme. Experiments supplying calcitriol bypass that conversion step. A precursor response raises a different mechanistic question: which cells converted it, and which cells subsequently responded? The conversion background is explained in Vitamin D Metabolism at the Cellular Level.
A blood concentration, receptor expression and the activity of an enzyme are also different measurements. Messenger RNA is a readout of gene activity, not direct proof of protein abundance or metabolic flux. These distinctions prevent a chain of assumed equivalences from turning a cellular finding into a clinical recommendation. This article describes research, not a pregnancy dosing plan or an individual blood target. The receptor background is introduced in Vitamin D Receptors.
Early placental cells: invasion in a laboratory model
Chan and colleagues studied primary extravillous trophoblasts obtained at 8 to 11 weeks of pregnancy. These are placental cells involved in establishing the maternal interface. Some exposures to calcitriol or its precursor increased movement through a laboratory barrier. This was a behavioural measurement, rather than simply finding a receptor in tissue.
The response did not establish that increasing exposure always increases invasion. The pattern was not consistently stronger at higher concentrations. An inhibitor experiment was compatible with local activation contributing to the precursor response, but ketoconazole affects several enzymes. It did not selectively prove that the vitamin D activating enzyme alone caused the effect. Protein binding is another relevant part of the exposure context; the carrier background is Vitamin D Transport Proteins.
The study also examined molecules involved in tissue remodelling. An associated change in such a molecule does not establish that it caused the observed movement. More importantly, the experiment did not measure successful implantation, improved fetal development or prevention of a pregnancy complication. Primary human cells provide useful biological relevance while still leaving those clinical questions open.
A second developmental model: migration and another signal
Westwood and colleagues examined sphingosine-1-phosphate, abbreviated S1P, a signalling molecule that affected trophoblast migration. Their programme included early human tissue and several cell models. Under the tested conditions, S1P reduced migration. Calcitriol reduced messenger RNA for S1PR2, a specific receptor for this signal, and attenuated the inhibition of migration in cell lines.
The distinction between experiments matters. The primary tissue work supported an effect of S1P; it did not itself establish that calcitriol restored migration in intact maternal-fetal tissue. Some models were immortalised, and one was tumour-derived. Neither a cell-line response nor reduced receptor messenger RNA fully isolates the causal pathway in a normal pregnancy.
Other model conditions have produced a different direction of S1P response. That does not erase this investigation, but it cautions against making a universal rule from one preparation. Chan and Westwood offer different experimental contributions to local developmental biology. They are not two clinical demonstrations that vitamin D improves fetal growth.
Direct immune experiments in maternal decidua
Evans and colleagues studied human decidual cells from early and late pregnancy. Early-pregnancy preparations showed greater conversion of precursor into active hormone. The study also examined uterine natural killer cells, a population of immune cells. Despite their name, their behaviour cannot be reduced to a single measure of cell killing.
Vitamin D exposure began in a mixed decidual-cell preparation before the natural killer cells were separated. Subsequent cytokine measurements therefore cannot prove that those isolated immune cells had activated the precursor by themselves. Cytokines are signalling molecules used by cells to communicate. Several measured cytokines decreased after exposure to precursor or calcitriol. The cytokine experiment used four separate decidual samples; the mixed-cell gene-expression experiments used five, and the killing assay used ten. These are small biological samples from separate assays, not independent clinical studies. The broader signalling concept is explained in Vitamin D and Cytokine Balance.
The negative findings are equally important. The experiment did not show a clear change in the cell-killing assay. Expression of an enzyme associated with immune regulation, indoleamine 2,3-dioxygenase, correlated with the vitamin D activating enzyme, but vitamin D treatment did not increase its messenger RNA. Correlation did not demonstrate regulation through that proposed route.
Messenger RNA for cathelicidin, an antimicrobial peptide, increased in mixed decidual cells. That was not a demonstration of protection against infection. These small experiments identify particular immune-related responses; they do not establish blanket immune suppression, successful fetal tolerance or a pregnancy treatment. The peptide background, distinct from proof of protection in this experiment, is introduced in Vitamin D and Antimicrobial Peptides.
Human tissue after pregnancy loss: association and timing
Li and colleagues compared decidual tissue from 30 women with recurrent pregnancy loss and 30 women undergoing elective termination. The cases were sampled after pregnancy failure; the controls had viable pregnancies at termination. Local 25-hydroxyvitamin D was lower in cases. Two measured immune-signalling molecules, interleukin-17 and interleukin-23, were higher, while transforming growth factor beta was lower. These measurements describe signals in tissue, not direct tests of immune-cell function. The vitamin D receptor signal was lower in cases, whereas the activating enzyme did not show a clear difference.
The timing prevents a simple causal reading. Tissue changes could precede loss, result from it or reflect differences in tissue composition and inflammation. This study did not prospectively demonstrate that low local vitamin D caused miscarriage. It did not test treatment or directly measure regulatory immune-cell function or antigen-specific tolerance.
A concentration in a tissue preparation is also not a validated blood-test threshold. Turning these observations into a serum target or a claim of preventable pregnancy loss would exceed the design. The study contributes local human evidence, but its limitations give it less causal weight than its title might suggest.
A contrary report could only be assessed through its abstract
Barrera and colleagues reported that calcitriol reduced interleukin-10 expression in cultured human trophoblasts, including inflammatory conditions. Interleukin-10 is often discussed as an anti-inflammatory signalling molecule. The reported direction therefore challenges a simple claim that vitamin D always raises anti-inflammatory cytokines.
For this review, only the publication’s abstract was accessible. Its full methods, results and figures could not be inspected. It is not counted as a fully assessed study. The reported direction is included openly, but detailed dose-response claims, the specificity of its receptor-blocking experiment and the proposed explanation cannot be weighed here.
The report should not be hidden because it complicates a favourable account. Equally, an abstract is insufficient to establish clinical harm or refute every finding in a different cell preparation. Trophoblasts and maternal decidual immune cells are different systems. The sound conclusion remains that a cytokine response needs its cellular and experimental context; one direction is not a universal measure of healthy tolerance.
Pregnancy outcomes supply a different kind of evidence
Raia-Barjat and colleagues analysed 182 women from the high-risk AngioPred pregnancy cohort. They measured maternal blood 25-hydroxyvitamin D repeatedly and examined placenta-associated complications, including pre-eclampsia and growth restriction. This was an observational analysis, not a randomised supplementation trial or a direct test of placental signalling.
The association was more apparent late in pregnancy. Earlier measurements did not clearly distinguish the outcome groups, and adjusted pre-eclampsia-specific results were not statistically clear. Supplementation and seasonal information were unavailable. Subclinical disease could also affect later concentrations before a complication was diagnosed.
These findings connect the discussion to clinically relevant outcomes, but do not demonstrate causal mediation or prevention. Some numerical and model descriptions were inconsistent, so this review does not use the disputed adjusted multiplier. The causal word in the publication title should not be adopted as the conclusion of this evidence review.
What the different measurements can establish
| Study and setting | What was measured | What was not established |
|---|---|---|
| Chan: early human placental cells | Invasion through a laboratory barrier | Successful implantation or improved fetal development |
| Westwood: tissue and cell models | S1P effects; calcitriol response in cell lines | An intact-pregnancy rescue or clinical benefit |
| Evans: maternal decidual cells | Selected cytokine/gene responses; no clear killing response | Proven maternal-fetal tolerance or infection protection |
| Li: tissue sampled after pregnancy loss | Local associations | Cause of loss or benefit from supplementation |
| AngioPred: high-risk pregnancy cohort | Late blood associations with complications | Causal mediation or prevention |
| Barrera: abstract-only report | Reported decrease in interleukin-10 | Fully appraised mechanism, magnitude or clinical consequence |
The table separates evidence by the question actually tested. A shared vitamin D topic does not make these measurements interchangeable. Giving each study a distinct contribution is more informative than treating favourable findings as votes. Multiple assays within one investigation are also not separate independent confirmations.
No participant overlap was identified between these five programmes, although that is not proof that every possible overlap has been excluded. Reuse of the Chan study in the separate placental metabolism review reflects a different scientific question. It does not create an additional study within this review. The AngioPred analysis likewise remains one cohort regardless of how many related reports exist.
Implications for fetal development and immune tolerance
The developmental experiments support the capacity of vitamin D compounds to influence selected placental-cell behaviours. The decidual experiments support local immune modulation, with important unchanged endpoints. Together they make a physiological contribution plausible. They do not show that all these responses occur together in an intact pregnancy, in the right place and at a beneficial intensity.
A complete causal account would need more than evidence that each proposed component exists. It would need to establish how local exposure changes a specified response, whether that response is necessary for the outcome and whether altering it improves the outcome without creating other problems. The present studies test parts of that account, not its entirety.
For fetal development, the unmeasured outcomes include organ development and later offspring health. For immune tolerance, altered cytokines and local tissue associations do not directly establish successful recognition and restraint at the maternal-fetal interface. These are genuine limits of the evidence, not proof that vitamin D has no relevant role.
Limits of this review
This is a selected narrative comparison of five investigations, with a sixth report retained as an abstract-only qualification. It is not a systematic review of every placental pathway or a pooled estimate of treatment benefit. Full principal text, relevant tables and figure descriptions were assessed for the five included investigations. Where actual figure images were unavailable, claims requiring their visual inspection or precise graph-only values were excluded. The Barrera access limit remains unresolved.
The evidence differs in pregnancy stage, tissue origin, compound, experimental exposure and outcome. Small cultured-cell experiments cannot define a personal supplement regimen. Nor can later observational blood measurements identify the cause of an earlier developmental event. The most defensible interpretation is specific local responsiveness with incomplete clinical translation. Research supports further investigation; it does not justify a promise of better fetal development or proven immune tolerance from additional vitamin D.
Sources
Related reading
1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3+ regulatory T cells through preferential expansion and usage of interleukin-2
The aim of this work was to identify the cytokine milieu required in vitro to promote Foxp3+ Treg cells in cultures containing 1,25(OH)2D3 at more moderate concentrations (10−7 m).
Original paper ↗Read more →Analysis of the Mediating Effect of Vitamin D via the TGF‐β1/Treg Pathway in the Pathogenesis of Childhood Primary Immune Thrombocytopenia
To investigate the role of vitamin D (VitD), transforming growth factor‐β1 (TGF‐β1), and regulatory T cells (Treg) in the pathogenesis of primary immune thrombocytopenia (ITP) in children.
Original paper ↗Read more →Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring
Metabolic syndrome is a disorder of energy use and storage, which is characterized by central obesity, dyslipidemia, and raised blood pressure and blood sugar levels.
Original paper ↗Read more →Maternal Vitamin D Deficiency and the Risk of Placental Abruption: A Cross-Sectional Study in a Greek Obstetric Population
The aim of this study was to investigate whether low maternal vitamin D levels are associated with an increased risk of placental abruption in pregnancies considered otherwise low-risk.
Original paper ↗Read more →The 25(OH)Vitamin D Status Affected the Effectiveness of Oligo Fucoidan in Patients with Chronic Hepatitis B Virus Infection with Immune Tolerance Phase
This study investigated how 25(OH)Vitamin D status affected the effectiveness of oligo fucoidan in patients with HBV infection in the immune tolerance phase.
Original paper ↗Read more →Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration
Failure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE).
Original paper ↗Read more →Vitamin D deficiency during late pregnancy mediates placenta-associated complications
Aim of the study was to evaluate the relationship between vitamin D status and the occurrence of placenta-mediated complications (PMCs) in a population at high risk.
Original paper ↗Read more →Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface
The objective of this study was to investigate 25-hydroxyvitamin D [25(OH) D] concentration and vitamin D receptor (VDR) expression in the decidual tissues of RSA patients.
Original paper ↗Read more →Placental Vitamin D Signalling, Fetal Development and Immune Tolerance: Study Summary
Plain-English findings on placental vitamin D signalling: what cell studies show, what remains uncertain, and why they do not prove pregnancy benefits.
Read more →Effect of Vitamin D Supplementation on the Cerebral Placental Ratio in Pregnancy Complicated with Early Fetal Growth Restriction
The aim is to assess the relationship between CPR and vitamin D supplementation in fetuses with early FGR.
Original paper ↗Read more →Association between maternal vitamin D, calcium, and inflammatory cytokines in Iraqi pregnant women with placental calcification
The pro-inflammatory marker TNF-α was significantly increased in G3 compared to the control group (p = 0.016).
Original paper ↗Read more →Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
This study characterized metabolomic profiles of maternal adipose tissue, placenta, and cord blood in pre-pregnancy obesity and explored links to adverse pregnancy outcomes (APOs).
Original paper ↗Read more →Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and Pregnancy Outcome
Vitamin D deficiency has been implicated in the pathogenesis of several pregnancy complications attributed to impaired or abnormal placental function, but there are few clues indicating the mechanistic role of vitamin D in their pathogenesis.
Original paper ↗Read more →Placental Vitamin D Metabolism and Transport: Full Evidence Review
Human placental experiments and pregnancy-trial samples clarify vitamin D uptake, local metabolism and limits of fetal-health interpretation.
Read more →COVID-19 during Gestation: Maternal Implications of Evoked Oxidative Stress and Iron Metabolism Impairment
The purpose of this study was to investigate, for the first time, the effects of COVID-19 infection during pregnancy with regard to the oxidative/antioxidant status in mothers’ serum and placenta, together with placental iron metabolism.
Original paper ↗Read more →Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond
The effects of vitamin D on the production and action of several cytokines has been intensively investigated in recent years.
Original paper ↗Read more →Maternal Vitamin D Status at Week 30 of Gestation and Offspring Cardio-Metabolic Health at 20 Years: A Prospective Cohort Study over Two Decades
The aim of the present study was to investigate the association between maternal serum concentration of vitamin D (25(OH)D) in week 30 of gestation and offspring cardio-metabolic risk factors at 20 years.
Original paper ↗Read more →Cohort profile: the Genetics of Glucose regulation in Gestation and Growth (Gen3G): a prospective prebirth cohort of mother-child pairs in Sherbrooke, Canada, 3-year and 5-year follow-up visits
We also investigated molecular mechanisms involved in the fetal programming of these later health outcomes.
Original paper ↗Read more →Vitamin D and Immune Tolerance
Immune tolerance is the ability of the immune system to avoid inappropriate reactions against self and harmless exposures.
Read more →Placental Vitamin D Metabolism and Transport: Study Summary
Plain-English summary of how the placenta takes up and changes vitamin D compounds, and why the findings do not prove better fetal health.
Read more →Vitamin D and Placental Function
Explore how vitamin D participates in placental physiology, supporting signalling, adaptation, and maternal: fetal regulation throughout pregnancy.
Read more →Original sources
Vitamin D promotes human extravillous trophoblast invasion in vitro
Published in Chan SY et al. Placenta (2015).
Publication details
Vitamin D promotes human extravillous trophoblast invasion in vitro. Chan SY et al. Placenta. 2015;36(4):403 to 409. DOI: 10.1016/j.placenta.2014.12.021.
Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration
Failure of trophoblast invasion and remodelling of maternal blood vessels leads to the pregnancy complication pre-eclampsia (PE).
Publication details
Vitamin D attenuates sphingosine-1-phosphate (S1P)-mediated inhibition of extravillous trophoblast migration. Westwood M et al. Placenta. 2017;60:1 to 8. DOI: 10.1016/j.placenta.2017.09.009.
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells
Published in Evans KN et al. Biology of Reproduction (2006).
Publication details
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells. Evans KN et al. Biology of Reproduction. 2006;75(6):816 to 822. DOI: 10.1095/biolreprod.106.054056.
Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface
The objective of this study was to investigate 25-hydroxyvitamin D [25(OH) D] concentration and vitamin D receptor (VDR) expression in the decidual tissues of RSA patients.
Publication details
Women with recurrent spontaneous abortion have decreased 25(OH) vitamin D and VDR at the fetal-maternal interface. Li N et al. Brazilian Journal of Medical and Biological Research. 2017;50(11):e6527. DOI: 10.1590/1414-431X20176527.
Vitamin D deficiency during late pregnancy mediates placenta-associated complications
Aim of the study was to evaluate the relationship between vitamin D status and the occurrence of placenta-mediated complications (PMCs) in a population at high risk.
Publication details
Vitamin D deficiency during late pregnancy mediates placenta-associated complications. Raia-Barjat T et al. Scientific Reports. 2021;11:20708. Observational AngioPred analysis; causal wording in the title is not adopted as this review’s conclusion. DOI: 10.1038/s41598-021-00250-5.
Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions
Published in Barrera D et al. Cytokine (2012).
Publication details
Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions. Barrera D et al. Cytokine. 2012;57(3):316 to 321. ABSTRACT ONLY: full principal unavailable; not counted as fully assessed evidence. DOI: 10.1016/j.cyto.2011.11.020.